☆ 4.7 Article

Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway

GUT MICROBES (2023)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

Fusobacterium nucleatum promotes proliferation in oesophageal squamous cell carcinoma via AHR/CYP1A1 signalling

Haisen Yin et al.

Summary: Fusobacterium nucleatum (Fn) is involved in the progression of esophageal squamous cell carcinoma (ESCC) by promoting cell proliferation through the AHR/CYP1A1/AKT signaling pathway. These findings contribute to the development of therapeutic strategies for ESCC.

FEBS JOURNAL (2023)

Add to Collection

Article Multidisciplinary Sciences

Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer

Stella Paffenholz et al.

Summary: This study developed a fast and flexible mouse model to mimic the metastatic patterns and treatment response features of high-grade serous ovarian carcinoma. The research found that senescence propensity is a predictor of therapy response and a limited senescence-associated secretory phenotype could enhance the vulnerability of tumors to both chemotherapy and immune checkpoint blockade.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Add to Collection

Review Oncology

Hallmarks of Cancer: New Dimensions

Douglas Hanahan

Summary: The concept of the hallmarks of cancer is a tool for simplifying the complexity of cancer phenotypes and genotypes into basic principles. This article proposes phenotypic plasticity and disrupted differentiation as distinct hallmark capabilities, and discusses nonmutational epigenetic reprogramming and polymorphic microbiomes as enabling characteristics. Additionally, the importance of senescent cells in the tumor microenvironment is highlighted. The integrative concept of the hallmarks of cancer helps in understanding the mechanisms of cancer development and applying that knowledge to cancer medicine.

CANCER DISCOVERY (2022)

Add to Collection

Article Medicine, General & Internal

Fusobacterium nucleatum induces MDSCs enrichment via activation the NLRP3 inflammosome in ESCC cells, leading to cisplatin resistance

Mengxia Liang et al.

Summary: Fn infection can lead to high expression of NLRP3 and enrichment of MDSCs in ESCC, resulting in shortened survival time and resistance to CDDP in ESCC cells.

ANNALS OF MEDICINE (2022)

Add to Collection

Article Oncology

Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway

Daichi Nomoto et al.

Summary: Fusobacterium nucleatum influences the progression of gastrointestinal cancers by invading and occupying cancer cells, impacting gene and protein expression, and activating signaling pathways. This study provides insights into the mechanism of ESCC progression induced by F. nucleatum.

CANCER LETTERS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Cancer pharmacomicrobiomics: targeting microbiota to optimise cancer therapy outcomes

Nick Lung-Ngai Ting et al.

Summary: The relationship between gut microbiota and cancer treatment is crucial for enhancing therapeutic efficacy. Microbiota can be easily modified through various strategies, such as fecal microbiota transplantation, probiotics, and antibiotics. Studies have identified how microbes influence the pharmacokinetics and pharmacodynamics of cancer treatment. Clinical trials demonstrate the potential of microbiota modulation.

GUT (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Targeting the gut and tumor microbiota in cancer

Elizabeth M. Park et al.

Summary: This review highlights the potential of targeting microorganisms in personalized cancer care, the impact of microbes on cancer immunosurveillance and immunotherapy, and the development of novel therapeutic strategies targeting the microbiota. Evaluating a patient's microbial composition and function will be crucial in future multidisciplinary and precision medicine approaches.

NATURE MEDICINE (2022)

Add to Collection

Review Oncology

The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm

Longsha Liu et al.

Summary: The gut microbiome plays a crucial role in cancer therapy and has the potential to revolutionize the field. This review highlights the association between the gut microbiome and therapeutic response, and discusses strategies for integrating microbiome-modulating treatments with other cancer therapies.

JAMA ONCOLOGY (2022)

Add to Collection

Article Oncology

Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma

Yang Liu et al.

Summary: F. nucleatum infection was found to reduce chemotherapeutic response in ESCC patients, by modulating autophagy to induce resistance against 5-FU, CDDP, and Docetaxel. Targeting F. nucleatum during chemotherapy may lead to improved therapeutic outcomes for ESCC patients.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Article Oncology

Senescent cells in cancer therapy: why and how to remove them

Jian-Wei Zhang et al.

Summary: Cellular senescence is a stress response that can have detrimental effects during cancer therapy, including promoting tumorigenesis and therapeutic resistance. Selective removal of senescent cells is considered a promising adjuvant approach to eliminate these adverse effects.

CANCER LETTERS (2021)

Add to Collection

Article Oncology

Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence

Eliot Fletcher-Sananikone et al.

Summary: This study reveals that radiation therapy-induced senescence in non-neoplastic brain cells promotes the growth of glioblastoma. Senescent astrocytes secrete factors like HGF to activate Met in glioma cells. Treatment with senolytic drugs can attenuate tumor growth by selectively killing senescent astrocytes.

CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Article Pharmacology & Pharmacy

Senolytic-mediated elimination of head and neck tumor cells induced into senescence by cisplatin

Fereshteh Ahmadinejad et al.

MOLECULAR PHARMACOLOGY (2021)

Add to Collection

Review Pharmacology & Pharmacy

Advances and challenges in the treatment of esophageal cancer

Shiming He et al.

Summary: Esophageal cancer is a common and deadly cancer with two histological subtypes - esophageal squamous cell carcinoma and esophageal adenocarcinoma. Available treatment strategies include surgery, chemotherapy, and molecular targeted therapy, with poor prognosis. This review discusses the latest developments in chemotherapy, molecular targeted therapy, and immunotherapy for esophageal cancer.

ACTA PHARMACEUTICA SINICA B (2021)

Add to Collection

Article Oncology

Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy

Pataje G. Prasanna et al.

Summary: Cellular senescence is crucial in suppressing tumor growth, but radiation and chemotherapy can lead to accumulation of senescent cells in both tumor and normal tissues, potentially promoting tumor relapse and resistance to treatment. Targeting cellular senescence could be important in the fight against cancer.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Add to Collection

Review Multidisciplinary Sciences

The microbiome and human cancer

Gregory D. Sepich-Poore et al.

Summary: Microbes play significant roles in cancer, and bacteria, viruses, and fungi are believed to be key actors in cancer immunotherapy. Although the number of microbes known to directly cause carcinogenesis is small, further research is needed to understand the causal relationship between microbes and cancer.

SCIENCE (2021)

Add to Collection

Article Oncology

Fusobacterium Nucleatum Promotes the Development of Colorectal Cancer by Activating a Cytochrome P450/Epoxyoctadecenoic Acid Axis via TLR4/Keapl/NRF2 Signaling

Cheng Kong et al.

Summary: The study uncovers a mechanism by which Fusobacterium nucleatum regulates colorectal cancer metabolism to promote EMT and metastasis through activating the TLR4/Keap1/NRF2 axis to increase CYP2J2 and 12,13-EpOME. These findings provide potential therapeutic targets for patients infected with Fusobacterium nucleatum, highlighting the clinical utility of the CYP2J2/12,13-EpOME axis in colorectal cancer.

CANCER RESEARCH (2021)

Add to Collection

Article Oncology

Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients

Chirayu Mohindroo et al.

Summary: The use of antibiotics may predict outcomes in patients with pancreatic ductal adenocarcinoma (PDAC). In metastatic PDAC patients, antibiotic consumption is associated with significantly longer overall survival (OS) and progression-free survival (PFS). Antibiotics-associated modulation of the microbiome is linked to improved outcomes in metastatic PDAC patients.

CANCER MEDICINE (2021)

Add to Collection

Article Oncology

NAMPT Inhibition Suppresses Cancer Stem-like Cells Associated with Therapy-Induced Senescence in Ovarian Cancer

Timothy Nacarelli et al.

CANCER RESEARCH (2020)

Add to Collection

Article Oncology

Endothelial cells under therapy-induced senescence secrete CXCL11, which increases aggressiveness of breast cancer cells

Hyun Jung Hwang et al.

CANCER LETTERS (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Fusobacterium nucleatum host-cell binding and invasion induces IL-8 and CXCL1 secretion that drives colorectal cancer cell migration

Michael A. Casasanta et al.

SCIENCE SIGNALING (2020)

Add to Collection

Article Oncology

FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2

Pin Guo et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Medicine, General & Internal

Association between the use of antibiotics and efficacy of gemcitabine plus nab-paclitaxel in advanced pancreatic cancer

Shintaro Nakano et al.

MEDICINE (2020)

Add to Collection

Review Cell Biology

Senescence and the SASP: many therapeutic avenues

Jodie Birch et al.

GENES & DEVELOPMENT (2020)

Add to Collection

Article Oncology

Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma

Kensuke Yamamura et al.

CLINICAL CANCER RESEARCH (2019)

Add to Collection

Article Oncology

Antibiotic therapy augments the efficacy of gemcitabine-containing regimens for advanced cancer: a retrospective study

Hiroo Imai et al.

CANCER MANAGEMENT AND RESEARCH (2019)

Add to Collection

Article Cell Biology

Targeting normal and cancer senescent cells as a strategy of senotherapy

Ewa Sikora et al.

AGEING RESEARCH REVIEWS (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Cellular Senescence: Defining a Path Forward

Vassilis Gorgoulis et al.

CELL (2019)

Add to Collection

Review Cell Biology

The dynamic nature of senescence in cancer

Soyoung Lee et al.

NATURE CELL BIOLOGY (2019)

Add to Collection

Review Microbiology

Fusobacterium nucleatum - symbiont, opportunist and oncobacterium

Caitlin A. Brennan et al.

NATURE REVIEWS MICROBIOLOGY (2019)

Add to Collection

Review Oncology

Unmasking senescence: context-dependent effects of SASP in cancer

Douglas V. Faget et al.

NATURE REVIEWS CANCER (2019)

Add to Collection

Article Medicine, General & Internal

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani et al.

LANCET (2018)

Add to Collection

Review Cell Biology

Two-Step Senescence-Focused Cancer Therapies

Cynthia J. Sieben et al.

TRENDS IN CELL BIOLOGY (2018)

Add to Collection

Review Cell Biology

Hallmarks of Cellular Senescence

Alejandra Hernandez-Segura et al.

TRENDS IN CELL BIOLOGY (2018)

Add to Collection

Article Cell Biology

Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1/2-RSK1 pathway

Xuerong Sun et al.

CELL DEATH & DISEASE (2018)

Add to Collection

Correction Microbiology

FusoPortal: an Interactive Repository of Hybrid MinION-Sequenced Fusobacterium Genomes Improves Gene Identification and Characterization (vol 3, e00228-18, 2018)

Blake E. Sanders et al.

MSPHERE (2018)

Add to Collection

Article Oncology

Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse

Marco Demaria et al.

CANCER DISCOVERY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21

Yongzhi Yang et al.

GASTROENTEROLOGY (2017)

Add to Collection

Article Multidisciplinary Sciences

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

Leore T. Geller et al.

SCIENCE (2017)

Add to Collection

Article Multidisciplinary Sciences

Senescent tumor cells lead the collective invasion in thyroid cancer

Young Hwa Kim et al.

NATURE COMMUNICATIONS (2017)

Add to Collection

Article Microbiology

Perturbed human sub-networks by Fusobacterium nucleatum candidate virulence proteins

Andreas Zanzoni et al.

MICROBIOME (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy

TaChung Yu et al.

CELL (2017)

Add to Collection

Article Oncology

Human Microbiome Fusobacterium Nucleatum in Esophageal Cancer Tissue Is Associated with Prognosis

Kensuke Yamamura et al.

CLINICAL CANCER RESEARCH (2016)

Add to Collection

Article Medicine, Research & Experimental

Somatic TP53 Mutations in the Era of Genome Sequencing

Pierre Hainaut et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)

Add to Collection

Review Infectious Diseases

Potential burden of antibiotic resistance on surgery and cancer chemotherapy antibiotic prophylaxis in the USA: a literature review and modelling study

Aude Teillant et al.

LANCET INFECTIOUS DISEASES (2015)

Add to Collection

Article Microbiology

Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin

Mara Roxana Rubinstein et al.

CELL HOST & MICROBE (2013)

Add to Collection

Article Oncology

p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer

James G. Jackson et al.

CANCER CELL (2012)

Add to Collection

Review Cell Biology

Senescence: a new weapon for cancer therapy

Juan Carlos Acosta et al.

TRENDS IN CELL BIOLOGY (2012)

Add to Collection

Review Pathology

The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression

Jean -Philippe Coppe et al.

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)

Add to Collection

Article Cell Biology

Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion

Francis Rodier et al.

NATURE CELL BIOLOGY (2009)

Add to Collection

Article Biochemical Research Methods

Protocols to detect senescence-associated beta-galactosidase (SA-beta gal) activity, a biomarker of senescent cells in culture and in vivo

Florence Debacq-Chainiaux et al.

NATURE PROTOCOLS (2009)

Add to Collection

Article Multidisciplinary Sciences

Escherichia coli induces DNA double-strand breaks in eukaryotic cells

Jean-Philippe Nougayrede et al.

SCIENCE (2006)

Add to Collection

Article Oncology

X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

RL Camp et al.

CLINICAL CANCER RESEARCH (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.